PPV uptake in Wales in 2023/24
Authors: Vaccine Preventable Disease Programme, Communicable Disease Surveillance Centre
- All Wales/National
- Annual
Background
The pneumococcal polysaccharide vaccination (PPV) is currently offered to those aged 65 years and over and people aged two to 64 years in select clinical risk groups. PPV protects against 23 serotypes of Streptococcus pneumoniae that can cause pneumonia or serious invasive infections.
Data are presented by Local Authority/Health Board of GP and are based on all general practices in Wales as at end March 2024. All ages in this report are as at March 2024.
Data from one practice was excluded from this report due to data quality.
Key points
- Uptake of pneumococcal vaccine in people aged two to 64 years in a clinical risk group was 37.4% during 2023/24. Uptake ranged from 31.1% in Cwm Taf Morgannwg UHB to 46.8% in Betsi Cadwaladr UHB.
- Uptake of pneumococcal vaccine in people aged 65 years and over was 65.0% Uptake ranged from 59.8% in Swansea Bay UHB to 70.5% in Betsi Cadwaladr UHB.
- For those aged 65 and over, uptake increased with age (and time since eligibility). Uptake in those turning 65 was 31.1% whilst over 76% of those aged 75 and over were vaccinated.
- Amongst patients aged two to 64 years in a clinical risk group was highest in patients with a cochlear implant (73.6%), followed by patients with chronic respiratory disease (49.4%). Uptake was lowest in patients with chronic heart disease (29.8%).
- There are notable variations in uptake between and within health boards, especially in those under 65 years of age in clinical risk groups.
Table of contents:
Report downloads
PPV uptake in Wales in 2023-24
PDF, 556KB
Download PDF - PPV uptake in Wales in 2023-24 (556 KB)
Download PDFRelated reports
-
PPV uptake in Wales in 2022/23
Background The pneumococcal polysaccharide vaccination (PPV) is currently offered to those aged 65 years and older and people aged two to 64 years in select clinical risk groups. PPV protects […]
Published on: 31st March 2023
-
PPV uptake in Wales in 2019/20
Background The pneumococcal polysaccharide vaccination (PPV) is currently offered to those aged 65 years and over and people aged two to 64 years in select clinical risk groups. PPV protects […]
Published on: 31st March 2020
-
PPV uptake in Wales in 2020/21
Background The pneumococcal polysaccharide vaccination (PPV) is currently offered to those aged 65 years and older and people aged two to 64 years in select clinical risk groups. PPV protects […]
Published on: 31st March 2021